OpenAlex
Works that cite this article, indexed by OpenAlex.
Platforms, advances, and technical challenges in virus-like particles-based vaccines
Frontiers in Immunology 14 (2023)
Reeshu Gupta; Kajal Arora; Sourav Singha Roy; Abyson Joseph; Ruchir Rastogi; Nupur Mehrotra Arora; Prabuddha Kumar Kundu
Virus‐like particles as powerful vaccination strategy against human viruses
Reviews in Medical Virology 34(1) (2023)
Ikbel Hadj Hassine; Manel Ben M’hadheb-Gharbi; Mohammed A. Almalki; Jawhar Gharbi
Revolutionizing Nanovaccines: A New Era of Immunization
Vaccines 13(2) (2025)
Mohammed A. Saleh; Ahmed Y. El-Moghazy; Adel H. El-Gohary; WesamEldin I. A. Saber; Yosra A. Helmy
Modularized viromimetic polymer nanoparticle vaccines (VPNVaxs) to elicit durable and effective humoral immune responses
National Science Review 11(3) (2023)
Zichao Huang; Xinyu Zhuang; Liping Liu; Jiayu Zhao; Sheng Ma; Xinghui Si; Zhenyi Zhu; Fan Wu; Ningyi Jin; Mingyao Tian; Wantong Song; Xuesi Chen
mRNA and Adenoviral Vector Vaccine Platforms Utilized in COVID-19 Vaccines: Technologies, Ecosystem, and Future Directions
Vaccines 11(12) (2023)
Ryo Okuyama
Vaccine delivery systems and administration routes: Advanced biotechnological techniques to improve the immunization efficacy
Vaccine X 19 (2024)
Abdellatif Bouazzaoui; Ahmed A. H. Abdellatif
Prokaryote- and Eukaryote-Based Expression Systems: Advances in Post-Pandemic Viral Antigen Production for Vaccines
International Journal of Molecular Sciences 25(22) (2024)
Nelli S. Khudainazarova; Dmitriy L. Granovskiy; Olga A. Kondakova; Ekaterina M. Ryabchevskaya; Angelina O. Kovalenko; Ekaterina A. Evtushenko; Marina V. Arkhipenko; Nikolai A. Nikitin; Olga V. Karpova
COVID-19 Vaccines over Three Years after the Outbreak of the COVID-19 Epidemic
Viruses 15(9) (2023)
Aleksandra Anna Zasada; Aniela Darlińska; Aldona Wiatrzyk; Katarzyna Woźnica; Kamila Formińska; Urszula Czajka; Małgorzata Główka; Klaudia Lis; Paulina Górska
A perspective on SARS-CoV-2 virus-like particles vaccines
International Immunopharmacology 115 (2023)
Gao Xiaoyang; Yeting Xia; Xiaofang Liu; Yinlan Xu; Pengyang Lu; Zhipeng dong; Jing Liu; Gaofeng Liang
Viral protein-based nanoparticles (part 2): Pharmaceutical applications
European Journal of Pharmaceutical Sciences 189 (2023)
Rocio Mellid-Carballal; Sara Gutierrez-Gutierrez; Carmen Rivas; Marcos García-Fuentes
Exigency of Plant-Based Vaccine against COVID-19 Emergence as Pandemic Preparedness
Vaccines 11(8) (2023)
Anirudha Chattopadhyay; A. Abdul Kader Jailani; Bikash Mandal
Virus-like particles (VLPs)-based vaccines against COVID-19: Where do we stand amid the ongoing evolution of SARS-CoV-2?
Health Sciences Review 9 (2023)
Manish K. Dhawan; AbdulRahman A. Saied; Manish Kumar Sharma
Recent Developments in Silver Nanoparticles Utilized for Cancer Treatment and Diagnosis: a Patent Review
Pharmaceutical Patent Analyst 11(6) (2022)
Shripad M. Patil; Runjhun Tandon; Nitin Tandon
An Overview of Recent Developments in the Application of Antigen Displaying Vaccine Platforms: Hints for Future SARS-CoV-2 VLP Vaccines
Vaccines 11(9) (2023)
Doddy Irawan Setyo Utomo; Hamizah Suhaimi; Nor Azila Muhammad Azami; Fazren Azmi; Mohd Cairul Iqbal Mohd Amin; Jian Chu Xu
Controlling the Quality of Nanodrugs According to Their New Property—Radiothermal Emission
Pharmaceutics 16(2) (2024)
Gleb Vladimirovich Petrov; DARIA A. GALKINA; Alena Mikhailovna Koldina; Т. В. Гребенникова; Olesja Eliseeva; Yana Yu. Chernoryzh; Varvara V. Lebedeva; Anton Vladimirovich Syroeshkin
Immunogenicity of intraperitoneal and intranasal liposome adjuvanted VLP vaccines against SARS-CoV-2 infection
Scientific Reports 14(1) (2024)
Monrat Chulanetra; Primana Punnakitikashem; Kodchakorn Mahasongkram; Wanpen Chaicumpa; Kittirat Glab-ampai
Tuning the tropism and infectivity of SARS-CoV-2 virus-like particles for mRNA delivery
Nucleic Acids Research 53(5) (2025)
Qi Yang; Bruce A. Davidson; Petar Pajic; Xuyang Chen; Ömer Gökçümen; Min Gao; Sriram Neelamegham
Inducing Long Lasting B Cell and T Cell Immunity Against Multiple Variants of SARS‐CoV‐2 Through Mutant Bacteriophage Qβ—Receptor Binding Domain Conjugate
Advanced Healthcare Materials 13(20) (2024)
Zibin Tan; Canchai Yang; Po‐Han Lin; Sherif Ramadan; Weizhun Yang; Zahra Rashidi; Shuyao Lang; Fatemeh Shafieichaharberoud; Jia Gao; Xingling Pan; Nachy Soloff; Xuanjun Wu; Steven R. Bolin; Dohun Pyeon; Xuefei Huang
Large-Scale Purification and Characterization of Recombinant Receptor-Binding Domain (RBD) of SARS-CoV-2 Spike Protein Expressed in Yeast
Vaccines 11(10) (2023)
Gaurav Nagar; Siddharth Jain; Meghraj P. Rajurkar; Rakesh R. Lothe; Harish D. Rao; Sourav Majumdar; Manish Gautam; Sergio A. Rodriguez‐Aponte; Laura E. Crowell; John Christopher Love; Prajakta P. Dandekar; Amita Puranik; Sunil Gairola; Umesh S. Shaligram; Ratnesh D. Jain
A substitution at the cytoplasmic tail of the spike protein enhances SARS-CoV-2 infectivity and immunogenicity
EBioMedicine 110 (2024)
Yuhan Li; Xianwen Zhang; Wanbo Tai; Xinyu Zhuang; Huicheng Shi; Shumin Liao; Xinyang Yu; Rui Mei; Xingzhao Chen; Yanhong Huang; Yubin Liu; Jianying Liu; Yang Liu; Yibin Zhu; Penghua Wang; Mingyao Tian; Guocan Yu; Li Liang; Gong Cheng
An Overview of SARS-CoV-2 Etiopathogenesis and Recent Developments in COVID-19 Vaccines
Biomolecules 13(11) (2023)
Dona Susan Mathew; T Pandya; Het Pandya; Yuzen Vaghela; Selvakumar Subbian
Simian Immunodeficiency Virus-Based Virus-like Particles Are an Efficient Tool to Induce Persistent Anti-SARS-CoV-2 Spike Neutralizing Antibodies and Specific T Cells in Mice
Vaccines 13(3) (2025)
Alessandra Gallinaro; Chiara Falce; Maria Franca Pirillo; Martina Borghi; Felicia Grasso; Andrea Canitano; Serena Cecchetti; Marco Baratella; Zuleika Michelini; Sabrina Mariotti; Maria Vincenza Chiantore; Iole Farina; Antonio Di Virgilio; Antonella Tinari; Gabriella Scarlatti; Donatella R. M. Negri; Andrea Cara
VLP (Virus-Like Particles) Vaccines - Current Knowledge and Future Directions
Brazilian Archives of Biology and Technology 68 (2025)
Prakash Meghana; M.A. Jayasri; Krishnamurthy Suthindhiran
A Critical Assessment of COVID-19 Genomic Vaccines
Current Topics in Medicinal Chemistry 23(27) (2023)
Dima A. Sabbah; Rima Hajjo; Suhair Sunoqrot
Immunogenicity and safety of SARS-CoV-2 recombinant protein vaccine (CHO cell) LYB001 as a heterologous booster following two- or three-dose inactivated COVID-19 vaccine in adults aged ≥18 years: interim results of a randomized, active-controlled, double-blinded, phase 3 trial
Expert Review of Vaccines 24(1) (2024)
Beifang Yang; Jing Jin; Xiran He; Zhong-Hua Yang; Xiao′ai Qian; Ye-Qing Tong; Chang-Xian Ke; Zhao-Hong Li; Zhaoxia Li; Lin-Feng Zhong; Ze-Hong Gan; Xianfeng Zhang; Ying Zeng
Next-Generation Nanoparticle-Enabled mRNA Vaccines in the Treatment of COVID-19
Critical Reviews in Therapeutic Drug Carrier Systems 42(6) (2025)
Eknath B. Kole; Krishna Jadhav; Raghuraj Singh; Rahul Kumar Verma; Aniruddha Chatterjee; Jitendra Naik
COVID-19: The vaccine development strategies
Elsevier eBooks (2025)
Zhipeng Yan; Ming Yang; Ching‐Lung Lai
Acoustic Droplet Ejection High-Resolution Mass Spectrometry Enables High-Throughput Analysis of Proteins in Complex Biologic and Vaccine Matrices
Analytical Chemistry 98(34) (2026)
Jarrod Laro; Rodell C. Barrientos; Eli J. Larson; Erik L. Regalado; Emmanuel Appiah‐Amponsah; Chang Liu; Joseph R. Gouker; Devin M. Makey; Hang Hu; Ophelia I. Ukaegbu
SARS-CoV-2: A Comprehensive Insight into DNA, RNA, Subunit, and Viral Vaccines
Medical virology (2025)
Shaheda Tabassum